

CRISPR/Cas9 technology is a powerful tool for creating gene knock-ins and knock-outs. Using the ribonucleoprotein (RNP) system for delivering CRISPR/Cas9 has many advantages over the traditional plasmids or virus based delivery methods.GenScript now offers different grades of sgRNA solutions supporting from early discovery research, process development to clinical studies.
GenScript now offers GMP grade sgRNA service! More Details »
Advantages
- DNA free
- Detectable at high levels shortly after transfection
- Quickly cleared from the cell for less off-target effects
- Highly efficient even in hard-to-transfect cells
- Best for in vivo studies
GenScript provides comprehensive gRNA formats to support your CRISPR needs:
The easy yet effective one-step solution!
Synthetic single guide RNAs (sgRNAs) with modifications supporting easy and effective editing
- ✔ Option to deliver in 96-well plates supporting high throughput screening
-
Ready to use sgRNA
No in vitro transcription or annealing step needed
High KO efficiency
Even in hard-to-transfect cells
Flexible at scale
1 to 1000+ sgRNAs
2 to 100+ nmol
Why waste time on reagent preparation? Use one piece sgRNA avoiding unstable annealing

Synthetic sgRNA provides much better editing efficiency compared to IVT sgRNA
Did we mention that preparing IVT sgRNA from plasmid template takes ~4 hours in-house?
Product | Quantity | Pricing | Quote |
---|---|---|---|
EasyEdit sgRNA | 2 nmol | $99 | Quote |
4 nmol | $149 | ||
10 nmol | $259 | ||
50 nmol | $799 | ||
100 nmol | $1,199 |
Add-On Items
Product | Quantity | Pricing | Quote |
---|---|---|---|
Custom Primer for Assessing Editing Efficiency | 2 nmol | $1.2/nt | Quote |
EasyEdit Human HPRT Positive Control sgRNA | 2 nmol | $39 | Quote |
SafeEdit Human HPRT Positive Control sgRNA | 2 nmol | $69 | Quote |
Human HPRT Primer Mix for Assessing Editing Efficiency | 2 nmol | $10 | Quote |
GenCRISPR™ Ultra NLS-Cas9 Nuclease (10 mg/ml) | 500 μg | $695 | Quote |
1 mg | $1181.50 | ||
GenCRISPR™ Ultra eSpCas9-2NLS Nuclease (10 mg/ml) | 500 μg | $1245 | Quote |
1 mg | $2116.50 | ||
Long Single-Stranded DNA Synthesis for Gene Knock-In (151-5000 nt) | 3 μg and up | Starting at $0.8/nt | Quote |
Safeguard your cells!
HPLC purified high purity sgRNAs with modifications ensuring minimum off-target and cytotoxicity
- ✔ More than 90% purity guaranteed
- ✔ Ideal for primary cells and stem cell
-
Minimal impact for
cell viability Minimized off-target from truncated oligos
One stop shop from CRISPR machinery to knock-in templates
High purity SafeEdit sgRNA ensures minimal impact for cell viability

GenScript provides add-on QC options to ensure sustained quality of your cells:
- ✔ Mycoplasma testing (qPCR)
- ✔ Endotoxin testing (Kinetic LAL)
- ✔ Stability testing
- ✔ Cytotoxicity testing (co-culture with client specified cell line)
Contact us to learn more oligo@genscript.com
Choose HPLC purified sgRNA to avoid off-target from truncated oligos in samples

Product | Quantity | Pricing | Quote |
---|---|---|---|
SafeEdit sgRNA | 2 nmol | $199 | Quote |
4 nmol | $319 | ||
10 nmol | $579 | ||
50 nmol | $1,699 | ||
100 nmol | $2,499 |
Add-On Items
Product | Quantity | Pricing | Quote |
---|---|---|---|
Custom Primer for Assessing Editing Efficiency | 2 nmol | $1.2/nt | Quote |
EasyEdit Human HPRT Positive Control sgRNA | 2 nmol | $39 | Quote |
SafeEdit Human HPRT Positive Control sgRNA | 2 nmol | $69 | Quote |
Human HPRT Primer Mix for Assessing Editing Efficiency | 2 nmol | $10 | Quote |
GenCRISPR™ Ultra NLS-Cas9 Nuclease (10 mg/ml) | 500 μg | $695 | Quote |
1 mg | $1181.50 | ||
GenCRISPR™ Ultra eSpCas9-2NLS Nuclease (10 mg/ml) | 500 μg | $1245 | Quote |
1 mg | $2116.50 | ||
Long Single-Stranded DNA Synthesis for Gene Knock-In (151-5000 nt) | 3 μg and up | Starting at $0.8/nt | Quote |
GenScript now offers GMP sgRNA- Dedicated for IND and clinical phase I material production:
-
State-of-the-art production facility
Clean suite with class A isolator in a class C background Comprehensive QA/QC
Proprietary NGS method to verify sgRNA identityTrusted by scientific partners globally
Successfully delivered 30+ GMP grade batches
GMP sgRNA Production Workflow:

Contact oligo@genscript.com to learn more or Get a Quote
Resources
CRISPR/Cas9 system can be delivered into cells in many forms, including plasmids, lentivirus, adeno-associated virus, and ribonucleoprotein (RNP) complexes. CRISPR/Cas9 ribonucleoprotein (RNP) system are composed of Cas9 protein and either a single guide RNA (sgRNA) or a CRISPR RNA (crRNA) : trans-activating crRNA (tracrRNA) duplex.
- The crRNAs are 20 nt RNA oligonucleotides designed to be complementary to a genomic target. crRNA sequence design utilizes standard gRNA design principles and sequences can be easily selected from the GenScript gRNA database or customized using the GenScript gRNA design tool.
- The tracrRNAs are 67 nt RNA oligonucleotides which together with the crRNA and Cas9 nuclease, form the activated CRISPR/Cas9 RNP complex.
- A sgRNA is a single RNA oligo that contains both the crRNA sequence, which can identify target genomic sequence, and the tracrRNA sequence, which can form complex with Cas9 protein.
When either a sgRNA or a crRNA : tracrRNA duplex forms complex with Cas9 protein, they can together, create double strand breaks at a locus complementary to the 20 nt guide RNA sequence, 3-4 bp upstream from a protospacer adjacent motif (PAM) sequence (5\'-NGG-3\').

Unlike the traditional plasmids or lentivirus delivery methods, CRISPR/Cas9 RNP are delivered as intact complexes, and do not require cellular expression, thus has many advantages.
- DNA free
- Detectable at high levels shortly after transfection
- Quickly cleared from the cell for less off-target effects
- Highly efficient even in hard-to-transfect cells
- Best for in vivo studies
Recently, several studies have showed that sgRNA has better stability than crRNA:tracrRNA when duplexed with Cas9, thus leading to higher editing efficiency. Synthesis of 100 nt long sgRNAs was traditionally possible through in vitro-transcription (IVT) using phage RNA polymerase. These in vitro transcribed sgRNAs contain a 5’-triphosphate, which was thought to trigger immune response in many cell types. A recent study showed that sgRNAs with 5’-triphosphate modifications produced through in vitro-transcription can indeed induce innate immune responses and lead to cytotoxicity in human and murine cells. However, chemically synthesized sgRNAs without the 5’-triphosphate modifications demonstrated much better editing efficiency in cells, thus supporting that chemically synthesized sgRNAs are the most ideal reagent for CRISPR genome editing up till now1.
- Kim et al. CRISPR RNAs trigger innate immune responses in human cells. Genome Res. 2018. 28: 367-373.
-
How many sgRNA or crRNA sequences are needed for targeted knock-out? Read More »
-
What are the advantages of using synthetic sgRNA for gene editing compared to the traditional plasmids or virus based gRNA delivery methods? Read More »
- DNA free
- Detectable at high levels shortly after transfection
- Quickly cleared from the cell for less off-target effects
- Highly efficient even in hard-to-transfect cells
- Best for in vivo studies
-
What is the different between using synthetic sgRNA vs using crRNA: tracrRNA duplex? Read More »
-
What is the advantage of your sgRNAs compared to sgRNA synthesized from in vitro transcription? Read More »
-
Why should I choose modified sgRNA versus unmodified versions? Read More »
A minimum of 3 crRNA sequences are recommended to ensure knock-out and experimental accuracy. Independently obtained knock-out mutants provide redundancy to safeguard against any hidden off-target effects.
Unlike the traditional plasmids or lentivirus delivery methods, CRISPR/Cas9 RNP are delivered as intact complexes, and do not require cellular expression, thus has many advantages.
When using sgRNA, there is no need for annealing crRNA and tracrRNA duplex prior to use. More importantly, several studies have showed that sgRNA has better stability than crRNA:tracrRNA when duplexed with Cas9, thus leading to higher editing efficiency1,2.
1. Hendel, et al., Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells. Nat. Biotechnol., 33 (2015) 985-989.
2. Ryan et al., Improving CRISPR–Cas specificity with chemical modifications in single-guide RNAs. Nucleic Acids Research, 46 (2018) 2: 792–803.
Synthesis of 100 nt long sgRNAs was traditionally possible through in vitro-transcription (IVT) using phage RNA polymerase. These in vitro transcribed sgRNAs contain a 5’-triphosphate, which was thought to trigger immune response in many cell types. A recent study showed that sgRNAs with 5’-triphosphate modifications produced through in vitro-transcription can indeed induce innate immune responses and lead to cytotoxicity in human and murine cells. However, chemically synthesized sgRNAs without the 5’-triphosphate modifications demonstrated much better editing efficiency in cells, thus supporting that chemically synthesized sgRNAs are the most ideal reagent for CRISPR genome editing up till now3.
3. Kim et al. CRISPR RNAs trigger innate immune responses in human cells. Genome Res. 2018. 28: 367-373.
Our modified sgRNA has 2’-O-methyl and phosphorothioate modifications at the first three 5’ and 3’ terminal RNA residues.2′ O-Methyl oligo modification is best characterized as a RNA analog which offers stability against hydrolysis and nucleases. The phosphorothioate (PS) modification renders the internucleotide linkage more resistant to nuclease degradation.
Our customer service representatives are available 24 hours Monday through Friday. You may contact us anytime for assistance. Orders can be placed online, over the phone, by email or fax. Please have your payment information (credit card, purchase order or bank information) ready.